Merck and Moderna's experimental melanoma vaccine was administered to clinical trial patients in combination with an immune checkpoint inhibitor drug

Cancer & Oncology

Cancer treatment, oncology drug access, hematologic malignancies, and cancer drug policy.

225 claims·158 news stories

Opening sign-in…